JOURNEY IS THE DESTINATION: ASSESSING ASD AND CO-MORBID CONDITIONS

被引：0
|
作者：
Eapen, V. [1 ]
机构：
[1] UNSW Sydney, Acad Unit Child Psychiat Southwest Sydney AUCS, Sydney, NSW, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2019年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [21] The incidence and effect of interferon on co-morbid conditions in hepatitis C patients
    Manos, M. M.
    Zhao, W. K.
    Murphy, R. C.
    Shvachko, V. A.
    Wilcock, K.
    Jadidi, S.
    Quesenberry, C. P.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S278 - S278
  • [22] Have co-morbid conditions changed in today's burn patients?
    Kishikova, Lyudmila
    Odeyinde, Samuel
    Dheansa, Baljit
    BURNS, 2013, 39 (06) : 1325 - 1326
  • [23] Evaluation and Comparison of Bariatric Procedures in Obese Patients With Co-morbid Conditions
    Pawanindra, Lal
    Chander, J.
    Hadke, N. S.
    Vindal, A.
    Kiran, S.
    Shrivastava, N.
    OBESITY SURGERY, 2012, 22 (09) : 1403 - 1403
  • [24] Medical management of vulnerable populations and co-morbid conditions of victims of bioterrorism
    White, SR
    Henretig, FM
    Dukes, RG
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2002, 20 (02) : 365 - +
  • [25] Evolution of the co-morbid conditions of morbid obesity after bariatric surgery by the technique of the duodenal switch
    Vazquez Prado, A.
    Montalva Oron, E. M.
    de Tursi Rispoli, L.
    Ismail Mahmoud, A.
    Redondo Cano, C.
    OBESITY SURGERY, 2007, 17 (02) : 280 - 280
  • [26] Clinical efficacy of omalizumab in severe persistent asthma and co-morbid conditions
    Yalcin, A.
    Bisgin, A.
    Cetinkaya, R.
    Gumuslu, S.
    ALLERGY, 2011, 66 : 366 - 366
  • [27] Sexual disorders, developmental disorders, developmental delay, and co-morbid conditions
    Fedoroff, JP
    Fedoroff, BI
    Ilic, K
    16TH ANNUAL CONFERENCE ON THE DAWN OF A NEW ERA: REFLECTING ON THE PAST, MOVING TOWARD THE FUTURE, 1999, : 90 - 96
  • [28] Pharmacological management of co-morbid conditions at the end of life: is less more?
    S. McLean
    B. Sheehy-Skeffington
    N. O’Leary
    A. O’Gorman
    Irish Journal of Medical Science, 2013, 182 : 107 - 112
  • [29] MULTIPLE CO-MORBID CONDITIONS IN PATIENT WITH MAST CELL ACTIVATION SYNDROME
    Szari, S.
    Quinn, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S85 - S86
  • [30] THE INCIDENCE OF CO-MORBID MEDICAL CONDITIONS AMONGST PATIENTS WITH AORTIC STENOSIS
    Halim, Khalda
    Shah, Benoy
    Kipourou, Konstantina
    HEART, 2023, 109 : A31 - A32
12345